Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease.

Bo Kyung KooSung Hee UmDong Soo SeoSae Kyung JooJeong Mo BaeJeong Hwan ParkMee Soo ChangJung Ho KimJieun LeeWon-Il JeongWon Kim

Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)

Our findings suggest that GDF15 may serve as a novel biomarker of advanced fibrosis in NAFLD, thereby indicating the need for urgent anti-fibrotic pharmacotherapy.

Keyphrases

liver fibrosis
systemic sclerosis
idiopathic pulmonary fibrosis
ultrasound guided
smoking cessation